Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hemofarm A.D.filedCriticalHemofarm A.D.
Priority to YUP-235/02ApriorityCriticalpatent/RS50500B/en
Publication of YU23502ApublicationCriticalpatent/YU23502A/en
Publication of RS50500BpublicationCriticalpatent/RS50500B/en
Farmaceutski proizvod u obliku efervescentne tablete, naznačen time, što se sastoji od efervescentnog granulata koga čine stabilizovana jezgra sa metilprednizolon hidrogensukcinatom ili natrijumovom soli metilprednizolon sukcinata, natrijum i/ili kalijum karbonat i dokusat natrijum, obložena slojem ) citratno-puferne supstance i ostale farmaceutski prihvatljive komponente.Prijava sadrži još 5 patentnih zahteva.Pharmaceutical product in the form of an effervescent tablet, consisting of an effervescent granulate consisting of a stabilized nucleus with methylprednisolone hydrogensuccinate or the sodium salt of methylprednisolone succinate, sodium and / or potassium carbonate and docusate sodium, citrate acceptable components.The application contains 5 more patent claims.
YUP-235/02A2002-03-292002-03-29The effervescent pharmaceutical preparation methylprednisolone derivative and procedure for its obtaining
RS50500B
(en)